|
|
|
|
 |
|
SENSEX
|
 |
-65.35
|
-0.27%
|
|
24570.65
|
|
|
|
NIFTY
|
 |
-455.59
|
-0.58%
|
|
78499.17
|
|
|
|
Nasdaq
|
 |
342.27
|
1.30%
|
|
26690.62
|
|
|
|
Nikkei 225
|
 |
-76.55
|
-0.12%
|
|
65606.71
|
|
|
|
FTSE 100
|
 |
33.20
|
0.31%
|
|
10901.10
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
543245
|
|
ISIN Demat |
INE068V01023
|
|
Book Value (Rs) |
652.53
|
|
|
NSE Code |
GLAND
|
|
Dividend Yield % |
0.77
|
|
Market Cap (Rs) |
428987.55
|
|
|
TTM PE(x) |
33.01
|
|
TTM EPS(Rs) |
78.78
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
20-03 1978
|
|
Registered Office
|
Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal- Gandimaisamma Mandal,Medchal- Malkajgiri District, Hyderabad, Telangana-500043 .
|
|
ISINNO
|
INE068V01023
|
|
Phone
|
040 30510999
|
|
E-mail
|
gland@glandpharma.com / investor@glandpharma.com |
|
URL
|
www.glandpharma.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Srinivas Sadu
|
|
Managing Director
|
|
|
Company Secretary
|
Sampath Kumar Pallerlamudi
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|